30 likes | 165 Views
ActD 0h. ActD 6h. 120.0. 100.0. 80.0. (% of ActD 0h). Reporter activity. 60.0. 40.0. 20.0. 0.0. AANAT. -. 3‘UTR. 1263. 449. 1889. 120. 100. 80. % of activity remaining. 60. 40. NAT. 3'U1889. 20. 3'U1263. 0. 0. 0.5. 1. 1.5. 2. [h]. Woo et al_.
E N D
ActD 0h ActD 6h 120.0 100.0 80.0 (% of ActD 0h) Reporter activity 60.0 40.0 20.0 0.0 AANAT - 3‘UTR 1263 449 1889 120 100 80 % of activity remaining 60 40 NAT 3'U1889 20 3'U1263 0 0 0.5 1 1.5 2 [h] Woo et al_ mper2 3′UTR end sequence is responsible for its own degradation Supplementary Fig. S1 A B
+ 3′U1889 3′U1877 + IP + 3′U1263 + 3′U1660 3′U449 + + + + 3′U1440 + PTB + Ab 3′U1263 #1 + + + + competitors SCN-N SCN-N + + + + + + 90.5 90.5 90.5 61.5 61.5 61.5 46.2 46.2 46.2 37.8 37.8 37.8 + + 3′U449 #1 competitor + + + 3′U1889 + + + + + 3′U449 + S100 + + ++ Cold-3′U449 purified-PTB4 (ng) 25 400 + + + NIH3T3-c 90.5 90.5 61.5 61.5 46.2 46.2 37.8 26 Woo et al_ PTB binds to pyrimidine tract in mper2 3′end sequence in SCN Supplementary Fig. S2 A B PIS C E D
Cyto. Nuc. 6 18 6 18 12 24 12 24 PTB hnRNP D (short Exp.) hnRNP D (long Exp.) 9 18 21 0 6 12 14 16 Cyto. Nuc. 18 0 6 12 14 16 Lamin B 14-3-3ξ Woo et al_ Cytoplasmic PTB differentially translocalizes at respective phase Supplementary Fig. S3 A B